RESCRIPTOR is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Delavirdine Mesylate.
Product ID | 49702-225_48868879-0671-42c2-ab7b-09ec8b98dcbe |
NDC | 49702-225 |
Product Type | Human Prescription Drug |
Proprietary Name | RESCRIPTOR |
Generic Name | Delavirdine Mesylate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2012-04-11 |
Marketing End Date | 2020-08-31 |
Marketing Category | NDA / NDA |
Application Number | NDA020705 |
Labeler Name | ViiV Healthcare Company |
Substance Name | DELAVIRDINE MESYLATE |
Active Ingredient Strength | 200 mg/1 |
Pharm Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Non-Nucleoside Analog [EXT] |
NDC Exclude Flag | N |
Marketing Start Date | 2012-04-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020705 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-04-11 |
Marketing End Date | 2020-08-31 |
Ingredient | Strength |
---|---|
DELAVIRDINE MESYLATE | 200 mg/1 |
SPL SET ID: | eb28dcd2-c457-4137-9eec-00062e5a601b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
49702-209 | RESCRIPTOR | delavirdine mesylate |
49702-225 | RESCRIPTOR | delavirdine mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RESCRIPTOR 74264307 1926253 Live/Registered |
PHIVCO-2 LLC 1992-04-09 |